Aspirin has a better effect on PIK3CA mutant colorectal cancer cells by PI3K/Akt/Raptor pathway

被引:28
作者
Chen, Zhihang [1 ]
Wang, Chun [2 ]
Dong, Hao [1 ]
Wang, Xing [1 ]
Gao, Feng [1 ]
Zhang, Sen [1 ]
Zhang, Xiaolong [1 ]
机构
[1] Guangxi Med Univ, Affiliated Hosp 1, Dept Colorectal & Anal Surg, Nanning 530021, Peoples R China
[2] Wuhan Univ, Dept Gastroenterol, Zhongnan Hosp, Wuhan 430000, Peoples R China
关键词
Colorectal cancer; Aspirin; PI3K; Akt; raptor pathway; PIK3CA mutated; A-INDUCED APOPTOSIS; PRIMARY PREVENTION; MTOR; MUTATIONS; PHOSPHORYLATION; AUTOPHAGY; DISEASE; GENE; LC3;
D O I
10.1186/s10020-020-0139-5
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Background Aspirin, as a non-steroidal anti-inflammatory drug, can improve the survival rate of patients with colorectal cancer, while aspirin is effective in patients with PIK3CA mutant colorectal cancer (CRC). However, the mechanism of aspirin in the treatment of PIK3CA mutated CRC patients remains unclear. Methods In this study, immunohistochemistry was used to detect the expression levels of PI3K and Raptor in colorectal cancer patients with PIK3CA mutation and PIK3CA wild-type patients. To demonstrate that aspirin has a better effect on the CRC of PIK3CA mutations in association with the PI3K/Akt/Raptor pathway, we used aspirin to treat PIK3CA mutant CRC cells (HCT-116 and RKO). Subsequently, the CCK8 assay and flow cytometry assay were used to detect the apoptosis of PIK3CA mutant CRC cells before and after aspirin use. Western blot was used to detect the changes of PI3K/Akt/Raptor-associated protein, autophagy protein microtubule associated protein 1 light chain 3 alpha (MAP1LC3A, LC3), beclin 1 (BECN1) and apoptosis protein BCL2-associated X protein/ BCL2 apoptosis regulator (Bax/Bcl2), Caspase 3 after treatment of CRC cells with PIK3CA mutation by aspirin. Results Phosphoinositide-3-kinase (PI3K) and regulatory associated protein of MTOR complex 1 (Raptor) protein expression levels were higher in PIK3CA-mutant patients than in IK3CA wild-type patients. The expression of Bax/Bcl2 increased after treatment indicates that aspirin can induce apoptosis of PIK3CA-mutant CRC cells. The expression level of MAP1LC3 (LC3) in cells increases with the concentration of aspirin demonstrates that aspirin can induce autophagy in CRC cells. After 48 h of treatment with aspirin, the phosphorylation of eukaryotic translation initiation factor 4E binding protein 1 (4E-BP1) and ribosomal protein S6 kinase B1 (S6K1) was reduced, cell proliferation has been inhibited. After treatment with aspirin, as phosphorylation of PI3K and Protein kinase B (PKB, Akt) was decreased, Raptor expression was also decreased. Conclusion Aspirin can regulate the proliferation, apoptosis and autophagy of CRC cells through the PI3K/Akt/Raptor pathway, affecting PIK3CA-mutant CRC.
引用
收藏
页数:13
相关论文
共 33 条
  • [1] Stimulation of de Novo Pyrimidine Synthesis by Growth Signaling Through mTOR and S6K1
    Ben-Sahra, Issam
    Howell, Jessica J.
    Asara, John M.
    Manning, Brendan D.
    [J]. SCIENCE, 2013, 339 (6125) : 1323 - 1328
  • [2] Aspirin Use for the Primary Prevention of Cardiovascular Disease and Colorectal Cancer: US Preventive Services Task Force Recommendation Statement
    Bibbins-Domingo, Kirsten
    [J]. ANNALS OF INTERNAL MEDICINE, 2016, 164 (12) : 836 - U103
  • [3] Autophagy, Immunity, and Microbial Adaptations
    Deretic, Vojo
    Levine, Beth
    [J]. CELL HOST & MICROBE, 2009, 5 (06) : 527 - 549
  • [4] Effect of aspirin and NSAIDs on risk and survival from colorectal cancer
    Din, Farhat V. N.
    Theodoratou, Evropi
    Farrington, Susan M.
    Tenesa, Albert
    Barnetson, Rebecca A.
    Cetnarskyj, Roseanne
    Stark, Lesley
    Porteous, Mary E.
    Campbell, Harry
    Dunlop, Malcolm G.
    [J]. GUT, 2010, 59 (12) : 1670 - U114
  • [5] Evaluation of PIK3CA Mutation As a Predictor of Benefit From Nonsteroidal Anti-Inflammatory Drug Therapy in Colorectal Cancer
    Domingo, Enric
    Church, David N.
    Sieber, Oliver
    Ramamoorthy, Rajarajan
    Yanagisawa, Yoko
    Johnstone, Elaine
    Davidson, Brian
    Kerr, David J.
    Tomlinson, Ian P. M.
    Midgley, Rachel
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (34) : 4297 - U34
  • [6] Mammalian cell size is controlled by mTOR and its downstream targets S6K1 and 4EBP1/eIF4E
    Fingar, DC
    Salama, S
    Tsou, C
    Harlow, E
    Blenis, J
    [J]. GENES & DEVELOPMENT, 2002, 16 (12) : 1472 - 1487
  • [7] mTOR pathway in colorectal cancer: an update
    Francipane, Maria Giovanna
    Lagasse, Eric
    [J]. ONCOTARGET, 2014, 5 (01) : 49 - 66
  • [8] Mcl-1, an early-induction molecule, modulates activin A-induced apoptosis and differentiation of CML cells
    Fukuchi, Y
    Kizaki, H
    Yamato, K
    Kawamura, C
    Umezawa, A
    Hata, J
    Nishihara, T
    Ikeda, Y
    [J]. ONCOGENE, 2001, 20 (06) : 704 - 713
  • [9] Hayakawa J, 2000, CANCER RES, V60, P5988
  • [10] ACTIN A-INDUCED APOPTOSIS IS SUPPRESSED BY BCL-2
    KOSEKI, T
    YAMATO, K
    KRAJEWSKI, S
    REED, JC
    TSUJIMOTO, Y
    NISHIHARA, T
    [J]. FEBS LETTERS, 1995, 376 (03) : 247 - 250